AllantoinvsVitamin K

Allantoin (5-ureidohydantoin) stimulates cell proliferation and tissue regeneration by promoting fibroblast activity, keratinocyte proliferation, and extracellular matrix synthesis including collagen and glycosaminoglycans. It acts as a mild keratolytic by promoting the natural desquamation process—loosening corneocyte adhesion and facilitating shedding—without the irritation, pH disruption, or barrier compromise associated with alpha- or beta-hydroxy acids. Allantoin has anti-inflammatory properties through modulation of prostaglandin synthesis (inhibiting COX-2 and reducing PGE2) and may downregulate pro-inflammatory cytokines. Its moisturizing effect comes from increasing the water-binding capacity of the extracellular matrix and stratum corneum; it is highly soluble and forms hydrogen bonds with water. Allantoin also promotes wound epithelialization. Its safety profile—non-irritating, non-sensitizing, non-comedogenic—makes it suitable for compromised skin, post-procedure care, and infant formulations.

Vitamin K (phytonadione/K1) is cofactor for gamma-glutamyl carboxylase, which carboxylates glutamic acid residues in clotting factors II, VII, IX, X and proteins S, C — essential for calcium binding and coagulation cascade activation. Topically promotes reabsorption of subcutaneous extravasated blood by activating local clotting cascades that convert leaked hemoglobin to biliverdin and bilirubin for clearance. Strengthens capillary walls, reduces vascular permeability. For vascular dark circles: improves vessel wall integrity, reduces hemosiderin deposition. Supports elastic fiber production through matrix Gla protein carboxylation. Has anti-inflammatory effects. Clinical use: bruising, post-procedure ecchymosis, periorbital vascular hyperpigmentation. Results require 4-8 weeks consistent application.